Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

01-12-2020 | Echinococcosis | Research article

The correlations between Th1 and Th2 cytokines in human alveolar echinococcosis

Authors: Xiao Ma, Xuefei Zhang, Jia Liu, Yufang Liu, Cunzhe Zhao, Huixia Cai, Wen Lei, Junying Ma, Haining Fan, Jianye Zhou, Na Liu, Jingxiao Zhang, Yongshun Wang, Wei Wang, Peizhen Zhan, Xiongying Zhang, Qing Zhang, Kemei Shi, Peiyun Liu

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

Alveolar echinococcosis (AE) is a zoonotic parasitic disease caused by Echinococcus multilocularis larval tapeworm infections in humans that severely impairs the health of affected patients in the northern hemisphere.

Methods

The expression levels of 20 cytokines associated with AE infection were measured by enzyme-linked immunosorbent assay, and the correlations between these cytokines were analysed in the R programming language.

Results

Serum cytokine levels differed among individuals in both the AE patient and healthy control groups. The results of the correlations among the cytokines showed obvious differences between the two groups. In the AE patients group, Th1 and Th2 cytokines formed a more complicated network than that in the healthy control group.

Conclusions

The altered correlations between Th1 and Th2 cytokines may be closely associated with AE infection, which may provide a new explanation for the essential differences between AE patients and healthy individuals.
Literature
1.
go back to reference Gencheva DG, Menchev DN, Penchev DK, Tokmakova MP. An incidental finding of heart echinococcosis in a patient with infective endocarditis: a case report. Folia Med (Plovdiv). 2017;59:110–3.CrossRef Gencheva DG, Menchev DN, Penchev DK, Tokmakova MP. An incidental finding of heart echinococcosis in a patient with infective endocarditis: a case report. Folia Med (Plovdiv). 2017;59:110–3.CrossRef
2.
go back to reference Kern P, Silva AMD, Akhan O, Mullhaupt B, Vizcaychipi KA, Budke C, et al. The echinococcoses: diagnosis, clinical management and burden of disease. Adv Parasitol. 2017;96:259–369.CrossRef Kern P, Silva AMD, Akhan O, Mullhaupt B, Vizcaychipi KA, Budke C, et al. The echinococcoses: diagnosis, clinical management and burden of disease. Adv Parasitol. 2017;96:259–369.CrossRef
3.
go back to reference Tamarozzi F, Mariconti M, Neumayr A, Brunetti E. The intermediate host immune response in cystic echinococcosis. Parasite Immunol. 2016;38:170–81.CrossRef Tamarozzi F, Mariconti M, Neumayr A, Brunetti E. The intermediate host immune response in cystic echinococcosis. Parasite Immunol. 2016;38:170–81.CrossRef
4.
go back to reference Wen H, Vuitton L, Tuxun T, Li J, Vuitton DA, Zhang W, et al. Echinococcosis: advances in the 21st century. Clin Microbiol Rev. 2019;32:e00075–18.CrossRef Wen H, Vuitton L, Tuxun T, Li J, Vuitton DA, Zhang W, et al. Echinococcosis: advances in the 21st century. Clin Microbiol Rev. 2019;32:e00075–18.CrossRef
5.
go back to reference Feng X, Qi X, Yang L, Duan X, Fang B, Gongsang Q, et al. Human cystic and alveolar echinococcosis in the Tibet autonomous region (TAR), China. J Helminthol. 2015;89:671–9.CrossRef Feng X, Qi X, Yang L, Duan X, Fang B, Gongsang Q, et al. Human cystic and alveolar echinococcosis in the Tibet autonomous region (TAR), China. J Helminthol. 2015;89:671–9.CrossRef
6.
go back to reference Baumann S, Shi R, Liu W, Bao H, Schmidberger J, Kratzer W, et al. Worldwide literature on epidemiology of human alveolar echinococcosis: a systematic review of research published in the twenty-first century. Infection. 2019;47:703–27.CrossRef Baumann S, Shi R, Liu W, Bao H, Schmidberger J, Kratzer W, et al. Worldwide literature on epidemiology of human alveolar echinococcosis: a systematic review of research published in the twenty-first century. Infection. 2019;47:703–27.CrossRef
7.
go back to reference Li T, Chen X, Zhen R, Qiu J, Qiu D, Xiao N, et al. Widespread co-endemicity of human cystic and alveolar echinococcosis on the eastern Tibetan plateau, Northwest Sichuan/Southeast Qinghai. China Acta Trop. 2010;113:248–56.CrossRef Li T, Chen X, Zhen R, Qiu J, Qiu D, Xiao N, et al. Widespread co-endemicity of human cystic and alveolar echinococcosis on the eastern Tibetan plateau, Northwest Sichuan/Southeast Qinghai. China Acta Trop. 2010;113:248–56.CrossRef
8.
go back to reference Nunnari G, Pinzone MR, Gruttadauria S, Celesia BM, Madeddu G, Malaguarnera G, et al. Hepatic echinococcosis: clinical and therapeutic aspects. World J Gastroenterol. 2012;18:1448–58.CrossRef Nunnari G, Pinzone MR, Gruttadauria S, Celesia BM, Madeddu G, Malaguarnera G, et al. Hepatic echinococcosis: clinical and therapeutic aspects. World J Gastroenterol. 2012;18:1448–58.CrossRef
9.
go back to reference Wang J, Jebbawi F, Bellanger AP, Beldi G, Millon L, Gottstein B. Immunotherapy of alveolar echinococcosis via PD-1/PD-L1 immune checkpoint blockade in mice. Parasite Immunol. 2018;40:e12596.CrossRef Wang J, Jebbawi F, Bellanger AP, Beldi G, Millon L, Gottstein B. Immunotherapy of alveolar echinococcosis via PD-1/PD-L1 immune checkpoint blockade in mice. Parasite Immunol. 2018;40:e12596.CrossRef
10.
go back to reference Tuxun T, Apaer S, Ma HZ, Zhang H, Aierken A, Lin RY, et al. The potential role of Th9 cell related cytokine and transcription factors in patients with hepatic alveolar echinococcosis. J Immunol Res. 2015;2015:895416.CrossRef Tuxun T, Apaer S, Ma HZ, Zhang H, Aierken A, Lin RY, et al. The potential role of Th9 cell related cytokine and transcription factors in patients with hepatic alveolar echinococcosis. J Immunol Res. 2015;2015:895416.CrossRef
11.
go back to reference Wang J, Cardoso R, Marreros N, Muller N, Lundstrom-Stadelmann B, Siffert M, et al. Foxp3+ T regulatory cells as a potential target for immunotherapy against primary infection with echinococcus multilocularis eggs. Infect Immun. 2018;86:e00542–18.PubMedPubMedCentral Wang J, Cardoso R, Marreros N, Muller N, Lundstrom-Stadelmann B, Siffert M, et al. Foxp3+ T regulatory cells as a potential target for immunotherapy against primary infection with echinococcus multilocularis eggs. Infect Immun. 2018;86:e00542–18.PubMedPubMedCentral
12.
go back to reference Mejri N, Hemphill A, Gottstein B. Triggering and modulation of the host-parasite interplay by Echinococcus multilocularis: a review. Parasitology. 2010;137:557–68.CrossRef Mejri N, Hemphill A, Gottstein B. Triggering and modulation of the host-parasite interplay by Echinococcus multilocularis: a review. Parasitology. 2010;137:557–68.CrossRef
13.
go back to reference Borish LC, Steinke JW. 2. Cytokines and chemokines. J Allergy Clin Immunol. 2003;111:S460–75.CrossRef Borish LC, Steinke JW. 2. Cytokines and chemokines. J Allergy Clin Immunol. 2003;111:S460–75.CrossRef
14.
go back to reference Wang J, Gottstein B. Immunoregulation in larval Echinococcus multilocularis infection. Parasite Immunol. 2016;38:182–92.CrossRef Wang J, Gottstein B. Immunoregulation in larval Echinococcus multilocularis infection. Parasite Immunol. 2016;38:182–92.CrossRef
15.
go back to reference Pakala T, Molina M, Wu GY. Hepatic echinococcal cysts: a review. J Clin Transl Hepatol. 2016;4:39–46.CrossRef Pakala T, Molina M, Wu GY. Hepatic echinococcal cysts: a review. J Clin Transl Hepatol. 2016;4:39–46.CrossRef
16.
go back to reference Killcoyne S, Carter GW, Smith J, Boyle J. Cytoscape: a community-based framework for network modeling. Methods Mol Biol. 2009;563:219–39.CrossRef Killcoyne S, Carter GW, Smith J, Boyle J. Cytoscape: a community-based framework for network modeling. Methods Mol Biol. 2009;563:219–39.CrossRef
17.
go back to reference Kilwinski J, Jenne L, Jellen-Ritter A, Radloff P, Flick W, Kern P. T lymphocyte cytokine profile at a single cell level in alveolar echinococcosis. Cytokine. 1999;11:373–81.CrossRef Kilwinski J, Jenne L, Jellen-Ritter A, Radloff P, Flick W, Kern P. T lymphocyte cytokine profile at a single cell level in alveolar echinococcosis. Cytokine. 1999;11:373–81.CrossRef
18.
go back to reference Godot V, Harraga S, Beurton I, Deschaseaux M, Sarciron E, Gottstein B, et al. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. I. Comparison of patients with progressive and abortive lesions. Clin Exp Immunol. 2000;121:484–90.CrossRef Godot V, Harraga S, Beurton I, Deschaseaux M, Sarciron E, Gottstein B, et al. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. I. Comparison of patients with progressive and abortive lesions. Clin Exp Immunol. 2000;121:484–90.CrossRef
19.
go back to reference Wellinghausen N, Gebert P, Kern P. Interleukin (IL)-4, IL-10 and IL-12 profile in serum of patients with alveolar echinococcosis. Acta Trop. 1999;73:165–74.CrossRef Wellinghausen N, Gebert P, Kern P. Interleukin (IL)-4, IL-10 and IL-12 profile in serum of patients with alveolar echinococcosis. Acta Trop. 1999;73:165–74.CrossRef
20.
go back to reference Jenne L, Kilwinski J, Scheffold W, Kern P. IL-5 expressed by CD4+ lymphocytes from Echinococcus multilocularis-infected patients. Clin Exp Immunol. 1997;109:90–7.CrossRef Jenne L, Kilwinski J, Scheffold W, Kern P. IL-5 expressed by CD4+ lymphocytes from Echinococcus multilocularis-infected patients. Clin Exp Immunol. 1997;109:90–7.CrossRef
21.
go back to reference Tuxun T, Ma HZ, Apaer S, Zhang H, Aierken A, Li YP, et al. Expression of toll-like receptors 2 and 4 and related cytokines in patients with hepatic cystic and alveolar echinococcosis. Mediat Inflamm. 2015;2015:632760.CrossRef Tuxun T, Ma HZ, Apaer S, Zhang H, Aierken A, Li YP, et al. Expression of toll-like receptors 2 and 4 and related cytokines in patients with hepatic cystic and alveolar echinococcosis. Mediat Inflamm. 2015;2015:632760.CrossRef
22.
go back to reference Zhang S, Hue S, Sene D, Penfornis A, Bresson-Hadni S, Kantelip B, et al. Expression of major histocompatibility complex class I chain-related molecule a, NKG2D, and transforming growth factor-beta in the liver of humans with alveolar echinococcosis: new actors in the tolerance to parasites? J Infect Dis. 2008;197:1341–9.CrossRef Zhang S, Hue S, Sene D, Penfornis A, Bresson-Hadni S, Kantelip B, et al. Expression of major histocompatibility complex class I chain-related molecule a, NKG2D, and transforming growth factor-beta in the liver of humans with alveolar echinococcosis: new actors in the tolerance to parasites? J Infect Dis. 2008;197:1341–9.CrossRef
23.
go back to reference Bellanger AP, Mougey V, Pallandre JR, Gbaguidi-Haore H, Godet Y, Millon L. Echinococcus multilocularis vesicular fluid inhibits activation and proliferation of natural killer cells. Folia Parasitol (Praha). 2017;64:2017 029.CrossRef Bellanger AP, Mougey V, Pallandre JR, Gbaguidi-Haore H, Godet Y, Millon L. Echinococcus multilocularis vesicular fluid inhibits activation and proliferation of natural killer cells. Folia Parasitol (Praha). 2017;64:2017 029.CrossRef
24.
go back to reference Bellanger AP, Pallandre JR, Gbaguidi-Haore H, Knapp J, Malezieux N, Lignon T, et al. Investigating the impact of Echinococcus multilocularis vesicular fluid on human cells from healthy blood donors. J Immunol Methods. 2015;417:52–9.CrossRef Bellanger AP, Pallandre JR, Gbaguidi-Haore H, Knapp J, Malezieux N, Lignon T, et al. Investigating the impact of Echinococcus multilocularis vesicular fluid on human cells from healthy blood donors. J Immunol Methods. 2015;417:52–9.CrossRef
25.
go back to reference Dreweck CM, Soboslay PT, Schulz-Key H, Gottstein B, Kern P. Cytokine and chemokine secretion by human peripheral blood cells in response to viable Echinococcus multilocularis metacestode vesicles. Parasite Immunol. 1999;21:433–8.CrossRef Dreweck CM, Soboslay PT, Schulz-Key H, Gottstein B, Kern P. Cytokine and chemokine secretion by human peripheral blood cells in response to viable Echinococcus multilocularis metacestode vesicles. Parasite Immunol. 1999;21:433–8.CrossRef
26.
go back to reference Shi DZ, Li FR, Bartholomot B, Vuitton DA, Craig PS. Serum sIL-2R, TNF-alpha and IFN-gamma in alveolar echinococcosis. World J Gastroenterol. 2004;10:3674–6.CrossRef Shi DZ, Li FR, Bartholomot B, Vuitton DA, Craig PS. Serum sIL-2R, TNF-alpha and IFN-gamma in alveolar echinococcosis. World J Gastroenterol. 2004;10:3674–6.CrossRef
27.
go back to reference Lechner CJ, Gruner B, Huang X, Hoffmann WH, Kern P, Soboslay PT. Parasite-specific IL-17-type cytokine responses and soluble IL-17 receptor levels in alveolar echinococcosis patients. Clin Dev Immunol. 2012;2012:735342.CrossRef Lechner CJ, Gruner B, Huang X, Hoffmann WH, Kern P, Soboslay PT. Parasite-specific IL-17-type cytokine responses and soluble IL-17 receptor levels in alveolar echinococcosis patients. Clin Dev Immunol. 2012;2012:735342.CrossRef
28.
go back to reference Tuxun T, Apaer S, Ma HZ, Zhao JM, Lin RY, Aji T, et al. Plasma IL-23 and IL-5 as surrogate markers of lesion metabolic activity in patients with hepatic alveolar echinococcosis. Sci Rep. 2018;8:4417.CrossRef Tuxun T, Apaer S, Ma HZ, Zhao JM, Lin RY, Aji T, et al. Plasma IL-23 and IL-5 as surrogate markers of lesion metabolic activity in patients with hepatic alveolar echinococcosis. Sci Rep. 2018;8:4417.CrossRef
29.
go back to reference Harraga S, Godot V, Bresson-Hadni S, Mantion G, Vuitton DA. Profile of cytokine production within the periparasitic granuloma in human alveolar echinococcosis. Acta Trop. 2003;85:231–6.CrossRef Harraga S, Godot V, Bresson-Hadni S, Mantion G, Vuitton DA. Profile of cytokine production within the periparasitic granuloma in human alveolar echinococcosis. Acta Trop. 2003;85:231–6.CrossRef
30.
go back to reference Huang X, Gruner B, Lechner CJ, Kern P, Soboslay PT. Distinctive cytokine, chemokine, and antibody responses in Echinococcus multilocularis-infected patients with cured, stable, or progressive disease. Med Microbiol Immunol. 2014;203:185–93.CrossRef Huang X, Gruner B, Lechner CJ, Kern P, Soboslay PT. Distinctive cytokine, chemokine, and antibody responses in Echinococcus multilocularis-infected patients with cured, stable, or progressive disease. Med Microbiol Immunol. 2014;203:185–93.CrossRef
31.
go back to reference Kocherscheidt L, Flakowski AK, Gruner B, Hamm DM, Dietz K, Kern P, et al. Echinococcus multilocularis: inflammatory and regulatory chemokine responses in patients with progressive, stable and cured alveolar echinococcosis. Exp Parasitol. 2008;119:467–74.CrossRef Kocherscheidt L, Flakowski AK, Gruner B, Hamm DM, Dietz K, Kern P, et al. Echinococcus multilocularis: inflammatory and regulatory chemokine responses in patients with progressive, stable and cured alveolar echinococcosis. Exp Parasitol. 2008;119:467–74.CrossRef
32.
go back to reference Hubner MP, Manfras BJ, Margos MC, Eiffler D, Hoffmann WH, Schulz-Key H, et al. Echinococcus multilocularis metacestodes modulate cellular cytokine and chemokine release by peripheral blood mononuclear cells in alveolar echinococcosis patients. Clin Exp Immunol. 2006;145:243–51.CrossRef Hubner MP, Manfras BJ, Margos MC, Eiffler D, Hoffmann WH, Schulz-Key H, et al. Echinococcus multilocularis metacestodes modulate cellular cytokine and chemokine release by peripheral blood mononuclear cells in alveolar echinococcosis patients. Clin Exp Immunol. 2006;145:243–51.CrossRef
33.
go back to reference Siracusano A, Delunardo F, Teggi A, Elena O. Cystic Echinococcosis: aspects of immune response, Immunopathogenesis and immune evasion from the human host. Endocr Metab Immune Disord Drug Targets. 2012;12:16–23.CrossRef Siracusano A, Delunardo F, Teggi A, Elena O. Cystic Echinococcosis: aspects of immune response, Immunopathogenesis and immune evasion from the human host. Endocr Metab Immune Disord Drug Targets. 2012;12:16–23.CrossRef
34.
go back to reference Liance M, Ricard-Blum S, Emery I, Houin R, Vuitton DA. Echinococcus multilocularis infection in mice: in vivo treatment with a low dose of IFN-gamma decreases metacestode growth and liver fibrogenesis. Parasite. 1998;5:231–7.CrossRef Liance M, Ricard-Blum S, Emery I, Houin R, Vuitton DA. Echinococcus multilocularis infection in mice: in vivo treatment with a low dose of IFN-gamma decreases metacestode growth and liver fibrogenesis. Parasite. 1998;5:231–7.CrossRef
35.
go back to reference Emery I, Leclerc C, Sengphommachanh K, Vuitton DA, Liance M. In vivo treatment with recombinant IL-12 protects C57BL/6J mice against secondary alveolar echinococcosis. Parasite Immunol. 1998;20:81–91.CrossRef Emery I, Leclerc C, Sengphommachanh K, Vuitton DA, Liance M. In vivo treatment with recombinant IL-12 protects C57BL/6J mice against secondary alveolar echinococcosis. Parasite Immunol. 1998;20:81–91.CrossRef
36.
go back to reference Valot B, Rognon B, Prenel A, Baraquin A, Knapp J, Anelli M, et al. Screening of antigenic vesicular fluid proteins of Echinococcus multilocularis as potential viability biomarkers to monitor drug response in alveolar echinococcosis patients. Proteomics Clin Appl. 2017;11:1700010.CrossRef Valot B, Rognon B, Prenel A, Baraquin A, Knapp J, Anelli M, et al. Screening of antigenic vesicular fluid proteins of Echinococcus multilocularis as potential viability biomarkers to monitor drug response in alveolar echinococcosis patients. Proteomics Clin Appl. 2017;11:1700010.CrossRef
Metadata
Title
The correlations between Th1 and Th2 cytokines in human alveolar echinococcosis
Authors
Xiao Ma
Xuefei Zhang
Jia Liu
Yufang Liu
Cunzhe Zhao
Huixia Cai
Wen Lei
Junying Ma
Haining Fan
Jianye Zhou
Na Liu
Jingxiao Zhang
Yongshun Wang
Wei Wang
Peizhen Zhan
Xiongying Zhang
Qing Zhang
Kemei Shi
Peiyun Liu
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05135-y

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.